POSACONAZOL Viatris susp 40 mg/ml buvable 105 ml

7680682710027 CH-68271 J02AC04 08.06.0.

Active substances:

POSACONAZOL Viatris susp 40 mg/ml buvable 105 ml
POSACONAZOL Viatris susp 40 mg/ml buvable 105 ml
POSACONAZOL Viatris susp 40 mg/ml buvable 105 ml
1 / 3
google

Details

Product number
6827101
CPT
-
Packaging group
105
Unit
ml
Composition
posaconazolum 200 mg, acidum citricum monohydricum, natrii dihydrogenocitras anhydricus, natrii benzoas 10 mg, natrii laurilsulfas, simeticonum, methylcellulosum, acidum sorbicum, xanthani gummi, glycerolum, glucosum liquidum 2108.5 mg, E 171, aromatica (Kirschen), aqua purificata ad suspensionem pro 5 ml corresp. natrium 5.91 mg.

Articles (1)

Posaconazol Viatris 40 mg/ml, Suspension zum Einnehmen
suspension
105
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/01/2026
Patient information leaflet
Français
28/01/2026
Patient information leaflet
Italien
28/01/2026
Professional SmPC
Allemand
28/01/2026
Professional SmPC
Français
28/01/2026
Professional SmPC
Italien
28/01/2026

Detailed composition

Substance Quantity Type Category
posaconazolum
200.0 MG Substance Wirkstoff (Principe actif)
acidum citricum monohydricum
- Substance HNIDK
natrii dihydrogenocitras anhydricus
- Substance HNIDK
natrii benzoas
10.0 MG Substance HBESI
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
simeticonum
- Substance HNIDK
methylcellulosum
- Substance HNIDK
acidum sorbicum
- Substance HNIDK
xanthani gummi
- Substance HNIDK
glycerolum
- Substance HNIDK
glucosum liquidum
2108.5 MG Substance HBESI
E 171
- Substance FNIDK
aromatica
- Substance AROMA
aqua purificata
- Substance HNIDK
natrium
5.91 MG Substance HBESI

Reimbursement information

Public price
CHF 574.50
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/10/2021

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
68271
Drug name
Posaconazol Viatris, Suspension zum Einnehmen
Galenic form
SUOR
ATC Code
J02AC04
Authorization status
Z
Dispensation category
B
First authorization
19/07/2021
Authorization expiration date
31/12/9999
IT number
08.06.0.
Domain
Human medicine
Field of application
Pilzinfektionen

Packaging details

Description (FR)
POSACONAZOL Viatris susp 40 mg/ml buvable 105 ml
Description (DE)
POSACONAZOL Viatris Susp 40 mg/ml z Einnehm 105 ml
Market launch
19/07/2021
Narcotic (BTM)
No

Original drug

Noxafil, Konzentrat zur Herstellung einer Infusionslösung
CHF 382.60
View original

Other packaging sizes

Buy us a coffee Explore the data